25 related articles for article (PubMed ID: 21903248)
1. External validation of a nomogram predicting overall survival of patients diagnosed with endometrial cancer.
Polterauer S; Zhou Q; Grimm C; Seebacher V; Reinthaller A; Hofstetter G; Concin N; Leitao MM; Barakat RR; Abu-Rustum NR; Iasonos A
Gynecol Oncol; 2012 Jun; 125(3):526-30. PubMed ID: 22449735
[TBL] [Abstract][Full Text] [Related]
2. Validation of a nomogram predicting sentinel lymph node status in melanoma in an Irish population.
Woods JF; De Marchi JA; Lowery AJ; Hill AD
Ir J Med Sci; 2015 Dec; 184(4):769-73. PubMed ID: 24997756
[TBL] [Abstract][Full Text] [Related]
3. External validation of three prognostic models for overall survival in patients with advanced-stage epithelial ovarian cancer.
van de Laar R; IntHout J; Van Gorp T; Verdonschot S; van Altena AM; Gerestein CG; Massuger LF; Zusterzeel PL; Kruitwagen RF
Br J Cancer; 2014 Jan; 110(1):42-8. PubMed ID: 24253502
[TBL] [Abstract][Full Text] [Related]
4. Nomogram for predicting 5-year disease-specific mortality after primary surgery for epithelial ovarian cancer.
Barlin JN; Yu C; Hill EK; Zivanovic O; Kolev V; Levine DA; Sonoda Y; Abu-Rustum NR; Huh J; Barakat RR; Kattan MW; Chi DS
Gynecol Oncol; 2012 Apr; 125(1):25-30. PubMed ID: 22155261
[TBL] [Abstract][Full Text] [Related]
5. Development and Validation of Nomograms Predicting the Overall and the Cancer-Specific Survival in Endometrial Cancer Patients.
Li X; Fan Y; Dong Y; Cheng Y; Zhou J; Wang Z; Li X; Wang J
Front Med (Lausanne); 2020; 7():614629. PubMed ID: 33425959
[No Abstract] [Full Text] [Related]
6. Preoperative CT-based nomogram for predicting overall survival in women with non-endometrioid carcinomas of the uterine corpus.
Lakhman Y; Yakar D; Goldman DA; Katz SS; Vargas HA; Miccò M; Zheng J; Moskowitz CS; Soslow RA; Hricak H; Abu-Rustum NR; Sala E
Abdom Imaging; 2015 Aug; 40(6):1761-8. PubMed ID: 25549782
[TBL] [Abstract][Full Text] [Related]
7. An external validation study of nomograms designed to predict isolated loco-regional and distant endometrial cancer recurrences: how applicable are they?
Bendifallah S; Canlorbe G; Raimond E; Bazire L; Huguet F; Graesslin O; Rouzier R; Darai E; Ballester M
Br J Cancer; 2013 Sep; 109(6):1498-503. PubMed ID: 23989946
[TBL] [Abstract][Full Text] [Related]
8. The role of adjuvant treatment in endometrial cancer.
Schmitt G; Carl UM; Pape H; Vernimmen FJ
Strahlenther Onkol; 1994 Oct; 170(10):561-4. PubMed ID: 7974166
[TBL] [Abstract][Full Text] [Related]
9. Stage IB endometrial cancer. Does lymphadenectomy replace adjuvant radiotherapy?
Bottke D; Wiegel T; Kreienberg R; Kurzeder C; Sauer G
Strahlenther Onkol; 2007 Nov; 183(11):600-4. PubMed ID: 17960334
[TBL] [Abstract][Full Text] [Related]
10. Independent external validation of radiotherapy and its impact on the accuracy of a nomogram for predicting survival of women with endometrial cancer.
Koskas M; Bendifallah S; Luton D; Darai E; Rouzier R
Gynecol Oncol; 2011 Nov; 123(2):214-20. PubMed ID: 21903248
[TBL] [Abstract][Full Text] [Related]
11. Descriptive nomograms of adjuvant radiotherapy use and patterns of care analysis for stage I and II endometrial adenocarcinoma: A surveillance, epidemiology, and end results population study.
Lee CM; Szabo A; Shrieve DC; Macdonald OK; Tward JD; Skidmore TB; Gaffney DK
Cancer; 2007 Nov; 110(9):2092-100. PubMed ID: 17849468
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant brachytherapy removes survival disadvantage of local disease extension in stage IIIC endometrial cancer: a SEER registry analysis.
Rossi PJ; Jani AB; Horowitz IR; Johnstone PA
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):134-8. PubMed ID: 17855014
[TBL] [Abstract][Full Text] [Related]
13. A nomogram for predicting lymph node metastasis of presumed stage I and II endometrial cancer.
Bendifallah S; Genin AS; Naoura I; Chabbert Buffet N; Clavel Chapelon F; Haddad B; Luton D; Darai E; Rouzier R; Koskas M
Am J Obstet Gynecol; 2012 Sep; 207(3):197.e1-8. PubMed ID: 22939725
[TBL] [Abstract][Full Text] [Related]
14. Prediction model for estimating the survival benefit of adjuvant radiotherapy for gallbladder cancer.
Wang SJ; Fuller CD; Kim JS; Sittig DF; Thomas CR; Ravdin PM
J Clin Oncol; 2008 May; 26(13):2112-7. PubMed ID: 18378567
[TBL] [Abstract][Full Text] [Related]
15. Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder.
Karakiewicz PI; Shariat SF; Palapattu GS; Gilad AE; Lotan Y; Rogers CG; Vazina A; Gupta A; Bastian PJ; Perrotte P; Sagalowsky AI; Schoenberg M; Lerner SP
J Urol; 2006 Oct; 176(4 Pt 1):1354-61; discussion 1361-2. PubMed ID: 16952631
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
